Medicina
Departamento
Université de Sherbrooke
Sherbrooke, CanadáPublicaciones en colaboración con investigadores/as de Université de Sherbrooke (11)
2023
2021
-
Factors associated with fears due to COVID-19: A scleroderma patient-centered intervention network (SPIN) COVID-19 cohort study
Journal of Psychosomatic Research, Vol. 140
2019
-
New filovirus disease classification and nomenclature
Nature Reviews Microbiology
2018
-
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial
JAMA - Journal of the American Medical Association, Vol. 319, Núm. 1, pp. 38-48
-
Randomized feasibility trial of the Scleroderma patient-centered intervention network hand exercise program (SPIN-HAND): Study protocol
Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 91-97
-
The scleroderma patient-centered intervention network cohort: Baseline clinical features and comparison with other large scleroderma cohorts
Rheumatology (United Kingdom), Vol. 57, Núm. 9, pp. 1623-1631
-
Validation of the social interaction anxiety scale in scleroderma: A scleroderma patientcentered intervention network cohort study
Journal of Scleroderma and Related Disorders, Vol. 3, Núm. 1, pp. 98-105
2016
-
Examination of the association of sex and race/ethnicity with appearance concerns: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study
Clinical and Experimental Rheumatology, Vol. 34, pp. 92-99
2007
-
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: The EVEREST clinical status trials
Journal of the American Medical Association, Vol. 297, Núm. 12, pp. 1332-1343
2005
-
Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)
Journal of Cardiac Failure, Vol. 11, Núm. 4, pp. 260-269